PTC Therapeutics price target cut to $75 by RBC Capital
RBC Capital cut its price target for PTC Therapeutics to $75.00 from $85.00 and maintained a Sector Perform rating, per Benzinga.
Story updates
02:22:10 PM UTC
SquawkNews
PTC Therapeutics Price Target Cut to $75.00/Share From $85.00 by RBC Capital